Ubs Asset Management Americas Inc Moderna, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 3,585,966 shares of MRNA stock, worth $102 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,585,966

Previous 3,890,812 7.84%

Holding current value

$102 Million

Previous $260 Million 42.66%

% of portfolio

0.04%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$36.85 - $63.93 $11.2 Million - $19.5 Million	-304,846 Reduced 7.84%	3,585,966 $149 Million
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $1.26 Million - $2.48 Million	19,819 Added 0.51%	3,890,812 $260 Million
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $20 Million - $33 Million	197,950 Added 5.39%	3,870,993 $460 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $58.7 Million - $79.4 Million	687,913 Added 23.04%	3,673,043 $391 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $39.1 Million - $58.7 Million	562,058 Added 23.2%	2,985,130 $297 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $92.3 Million - $121 Million	957,566 Added 65.34%	2,423,072 $250 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $5.04 Million - $7.33 Million	37,179 Added 2.6%	1,465,506 $225 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $21.7 Million - $38.6 Million	183,681 Added 14.76%	1,428,327 $257 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $3.85 Million - $6.34 Million	32,649 Added 2.69%	1,244,646 $147 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $93,352 - $140,742	-797 Reduced 0.07%	1,211,997 $173 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $19.2 Million - $35.8 Million	-152,211 Reduced 11.15%	1,212,794 $209 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $12.6 Million - $20.5 Million	55,735 Added 4.26%	1,365,005 $347 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $24.8 Million - $54.2 Million	111,826 Added 9.34%	1,309,270 $504 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $34.2 Million - $61.9 Million	263,480 Added 28.21%	1,197,444 $281 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $142,807 - $243,261	-1,308 Reduced 0.14%	933,964 $122 Million
Q4 2020 Mar 01, 2021	BUY	$65.74 - $169.86 $8.47 Million - $21.9 Million	128,836 Added 15.98%	935,272 $97.7 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $4.62 Million - $8.06 Million	84,951 Added 11.77%	806,436 $57.1 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $12.2 Million - $33 Million	412,859 Added 133.77%	721,485 $46.3 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $3.69 Million - $6.55 Million	-207,269 Reduced 40.18%	308,626 $9.24 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $523,099 - $799,106	37,552 Added 7.85%	515,895 $10.1 Million
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $5.86 Million - $8.64 Million	478,343 New	478,343 $7.62 Million

Others Institutions Holding MRNA

# of Institutions

925

Shares Held

252M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $11.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Moderna, Inc. Transaction History